 | • レポートコード：MRC23Q35792 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の人工皮膚マトリックス市場について調査・分析し、世界の人工皮膚マトリックス市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（動物由来、ヒト由来）、用途別セグメント分析（病院、診療所）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、MTF Biologics、Allosource、Parametrics Medical、LifeNet Health、Gunze、Tissue Regenix、Zimmer Biomet、Integra LifeSciences、Organogenesis、Flower Orthopedics、Promethean、Wright Medical Group、Aziyo Biologics、RTI Surgical、MiMedx Group、Tides Medical、Ventris Medical、Vivex Biomedical、Aedicell、Amniox Medical、StimLabs、Skye Biologicsなどが含まれています。 世界の人工皮膚マトリックス市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、人工皮膚マトリックス市場規模を推定する際に考慮しました。本レポートは、人工皮膚マトリックスの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、人工皮膚マトリックスに関するビジネス上の意思決定に役立てることを目的としています。 ・人工皮膚マトリックス市場の概要 - 人工皮膚マトリックスのタイプ別セグメント - 世界の人工皮膚マトリックス市場規模：タイプ別分析（動物由来、ヒト由来） - 人工皮膚マトリックスの用途別セグメント - 世界の人工皮膚マトリックス市場規模：用途別分析（病院、診療所） - 世界の人工皮膚マトリックス市場規模予測（2018年-2029年） ・人工皮膚マトリックス市場の成長トレンド - 人工皮膚マトリックスの地域別市場規模（2018年-2029年） - 人工皮膚マトリックス市場ダイナミクス - 人工皮膚マトリックスの業界動向 - 人工皮膚マトリックス市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：動物由来、ヒト由来 - 世界の人工皮膚マトリックスのタイプ別市場規模（2018年-2023年） - 世界の人工皮膚マトリックスのタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、診療所 - 世界の人工皮膚マトリックスの用途別市場規模（2018年-2023年） - 世界の人工皮膚マトリックスの用途別市場規模（2024年-2029年） ・人工皮膚マトリックスの地域別市場規模 - 北米の人工皮膚マトリックス市場規模（2018年-2029年） - アメリカの人工皮膚マトリックス市場規模（2018年-2029年） - ヨーロッパの人工皮膚マトリックス市場規模（2018年-2029年） - アジア太平洋の人工皮膚マトリックス市場規模（2018年-2029年） - 中国の人工皮膚マトリックス市場規模（2018年-2029年） - 日本の人工皮膚マトリックス市場規模（2018年-2029年） - 韓国の人工皮膚マトリックス市場規模（2018年-2029年） - インドの人工皮膚マトリックス市場規模（2018年-2029年） - オーストラリアの人工皮膚マトリックス市場規模（2018年-2029年） - 中南米の人工皮膚マトリックス市場規模（2018年-2029年） - 中東・アフリカの人工皮膚マトリックス市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 MTF Biologics、Allosource、Parametrics Medical、LifeNet Health、Gunze、Tissue Regenix、Zimmer Biomet、Integra LifeSciences、Organogenesis、Flower Orthopedics、Promethean、Wright Medical Group、Aziyo Biologics、RTI Surgical、MiMedx Group、Tides Medical、Ventris Medical、Vivex Biomedical、Aedicell、Amniox Medical、StimLabs、Skye Biologics ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Artificial Dermal Matrix market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Artificial Dermal Matrix is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Artificial Dermal Matrix is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Artificial Dermal Matrix in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Artificial Dermal Matrix include MTF Biologics, Allosource, Parametrics Medical, LifeNet Health, Gunze, Tissue Regenix, Zimmer Biomet, Integra LifeSciences and Organogenesis, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Artificial Dermal Matrix, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Dermal Matrix.
The Artificial Dermal Matrix market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Artificial Dermal Matrix market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Dermal Matrix companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
MTF Biologics
Allosource
Parametrics Medical
LifeNet Health
Gunze
Tissue Regenix
Zimmer Biomet
Integra LifeSciences
Organogenesis
Flower Orthopedics
Promethean
Wright Medical Group
Aziyo Biologics
RTI Surgical
MiMedx Group
Tides Medical
Ventris Medical
Vivex Biomedical
Aedicell
Amniox Medical
StimLabs
Skye Biologics
Segment by Type
From Animal Source
From Human Source
Segment by Application
Hospitals
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Dermal Matrix companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Dermal Matrix Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 From Animal Source
1.2.3 From Human Source
1.3 Market by Application
1.3.1 Global Artificial Dermal Matrix Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Dermal Matrix Market Perspective (2018-2029)
2.2 Artificial Dermal Matrix Growth Trends by Region
2.2.1 Global Artificial Dermal Matrix Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Artificial Dermal Matrix Historic Market Size by Region (2018-2023)
2.2.3 Artificial Dermal Matrix Forecasted Market Size by Region (2024-2029)
2.3 Artificial Dermal Matrix Market Dynamics
2.3.1 Artificial Dermal Matrix Industry Trends
2.3.2 Artificial Dermal Matrix Market Drivers
2.3.3 Artificial Dermal Matrix Market Challenges
2.3.4 Artificial Dermal Matrix Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Dermal Matrix Players by Revenue
3.1.1 Global Top Artificial Dermal Matrix Players by Revenue (2018-2023)
3.1.2 Global Artificial Dermal Matrix Revenue Market Share by Players (2018-2023)
3.2 Global Artificial Dermal Matrix Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Dermal Matrix Revenue
3.4 Global Artificial Dermal Matrix Market Concentration Ratio
3.4.1 Global Artificial Dermal Matrix Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Dermal Matrix Revenue in 2022
3.5 Artificial Dermal Matrix Key Players Head office and Area Served
3.6 Key Players Artificial Dermal Matrix Product Solution and Service
3.7 Date of Enter into Artificial Dermal Matrix Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Dermal Matrix Breakdown Data by Type
4.1 Global Artificial Dermal Matrix Historic Market Size by Type (2018-2023)
4.2 Global Artificial Dermal Matrix Forecasted Market Size by Type (2024-2029)
5 Artificial Dermal Matrix Breakdown Data by Application
5.1 Global Artificial Dermal Matrix Historic Market Size by Application (2018-2023)
5.2 Global Artificial Dermal Matrix Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Artificial Dermal Matrix Market Size (2018-2029)
6.2 North America Artificial Dermal Matrix Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Artificial Dermal Matrix Market Size by Country (2018-2023)
6.4 North America Artificial Dermal Matrix Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Dermal Matrix Market Size (2018-2029)
7.2 Europe Artificial Dermal Matrix Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Artificial Dermal Matrix Market Size by Country (2018-2023)
7.4 Europe Artificial Dermal Matrix Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Dermal Matrix Market Size (2018-2029)
8.2 Asia-Pacific Artificial Dermal Matrix Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Artificial Dermal Matrix Market Size by Region (2018-2023)
8.4 Asia-Pacific Artificial Dermal Matrix Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Dermal Matrix Market Size (2018-2029)
9.2 Latin America Artificial Dermal Matrix Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Artificial Dermal Matrix Market Size by Country (2018-2023)
9.4 Latin America Artificial Dermal Matrix Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Dermal Matrix Market Size (2018-2029)
10.2 Middle East & Africa Artificial Dermal Matrix Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Artificial Dermal Matrix Market Size by Country (2018-2023)
10.4 Middle East & Africa Artificial Dermal Matrix Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 MTF Biologics
11.1.1 MTF Biologics Company Detail
11.1.2 MTF Biologics Business Overview
11.1.3 MTF Biologics Artificial Dermal Matrix Introduction
11.1.4 MTF Biologics Revenue in Artificial Dermal Matrix Business (2018-2023)
11.1.5 MTF Biologics Recent Development
11.2 Allosource
11.2.1 Allosource Company Detail
11.2.2 Allosource Business Overview
11.2.3 Allosource Artificial Dermal Matrix Introduction
11.2.4 Allosource Revenue in Artificial Dermal Matrix Business (2018-2023)
11.2.5 Allosource Recent Development
11.3 Parametrics Medical
11.3.1 Parametrics Medical Company Detail
11.3.2 Parametrics Medical Business Overview
11.3.3 Parametrics Medical Artificial Dermal Matrix Introduction
11.3.4 Parametrics Medical Revenue in Artificial Dermal Matrix Business (2018-2023)
11.3.5 Parametrics Medical Recent Development
11.4 LifeNet Health
11.4.1 LifeNet Health Company Detail
11.4.2 LifeNet Health Business Overview
11.4.3 LifeNet Health Artificial Dermal Matrix Introduction
11.4.4 LifeNet Health Revenue in Artificial Dermal Matrix Business (2018-2023)
11.4.5 LifeNet Health Recent Development
11.5 Gunze
11.5.1 Gunze Company Detail
11.5.2 Gunze Business Overview
11.5.3 Gunze Artificial Dermal Matrix Introduction
11.5.4 Gunze Revenue in Artificial Dermal Matrix Business (2018-2023)
11.5.5 Gunze Recent Development
11.6 Tissue Regenix
11.6.1 Tissue Regenix Company Detail
11.6.2 Tissue Regenix Business Overview
11.6.3 Tissue Regenix Artificial Dermal Matrix Introduction
11.6.4 Tissue Regenix Revenue in Artificial Dermal Matrix Business (2018-2023)
11.6.5 Tissue Regenix Recent Development
11.7 Zimmer Biomet
11.7.1 Zimmer Biomet Company Detail
11.7.2 Zimmer Biomet Business Overview
11.7.3 Zimmer Biomet Artificial Dermal Matrix Introduction
11.7.4 Zimmer Biomet Revenue in Artificial Dermal Matrix Business (2018-2023)
11.7.5 Zimmer Biomet Recent Development
11.8 Integra LifeSciences
11.8.1 Integra LifeSciences Company Detail
11.8.2 Integra LifeSciences Business Overview
11.8.3 Integra LifeSciences Artificial Dermal Matrix Introduction
11.8.4 Integra LifeSciences Revenue in Artificial Dermal Matrix Business (2018-2023)
11.8.5 Integra LifeSciences Recent Development
11.9 Organogenesis
11.9.1 Organogenesis Company Detail
11.9.2 Organogenesis Business Overview
11.9.3 Organogenesis Artificial Dermal Matrix Introduction
11.9.4 Organogenesis Revenue in Artificial Dermal Matrix Business (2018-2023)
11.9.5 Organogenesis Recent Development
11.10 Flower Orthopedics
11.10.1 Flower Orthopedics Company Detail
11.10.2 Flower Orthopedics Business Overview
11.10.3 Flower Orthopedics Artificial Dermal Matrix Introduction
11.10.4 Flower Orthopedics Revenue in Artificial Dermal Matrix Business (2018-2023)
11.10.5 Flower Orthopedics Recent Development
11.11 Promethean
11.11.1 Promethean Company Detail
11.11.2 Promethean Business Overview
11.11.3 Promethean Artificial Dermal Matrix Introduction
11.11.4 Promethean Revenue in Artificial Dermal Matrix Business (2018-2023)
11.11.5 Promethean Recent Development
11.12 Wright Medical Group
11.12.1 Wright Medical Group Company Detail
11.12.2 Wright Medical Group Business Overview
11.12.3 Wright Medical Group Artificial Dermal Matrix Introduction
11.12.4 Wright Medical Group Revenue in Artificial Dermal Matrix Business (2018-2023)
11.12.5 Wright Medical Group Recent Development
11.13 Aziyo Biologics
11.13.1 Aziyo Biologics Company Detail
11.13.2 Aziyo Biologics Business Overview
11.13.3 Aziyo Biologics Artificial Dermal Matrix Introduction
11.13.4 Aziyo Biologics Revenue in Artificial Dermal Matrix Business (2018-2023)
11.13.5 Aziyo Biologics Recent Development
11.14 RTI Surgical
11.14.1 RTI Surgical Company Detail
11.14.2 RTI Surgical Business Overview
11.14.3 RTI Surgical Artificial Dermal Matrix Introduction
11.14.4 RTI Surgical Revenue in Artificial Dermal Matrix Business (2018-2023)
11.14.5 RTI Surgical Recent Development
11.15 MiMedx Group
11.15.1 MiMedx Group Company Detail
11.15.2 MiMedx Group Business Overview
11.15.3 MiMedx Group Artificial Dermal Matrix Introduction
11.15.4 MiMedx Group Revenue in Artificial Dermal Matrix Business (2018-2023)
11.15.5 MiMedx Group Recent Development
11.16 Tides Medical
11.16.1 Tides Medical Company Detail
11.16.2 Tides Medical Business Overview
11.16.3 Tides Medical Artificial Dermal Matrix Introduction
11.16.4 Tides Medical Revenue in Artificial Dermal Matrix Business (2018-2023)
11.16.5 Tides Medical Recent Development
11.17 Ventris Medical
11.17.1 Ventris Medical Company Detail
11.17.2 Ventris Medical Business Overview
11.17.3 Ventris Medical Artificial Dermal Matrix Introduction
11.17.4 Ventris Medical Revenue in Artificial Dermal Matrix Business (2018-2023)
11.17.5 Ventris Medical Recent Development
11.18 Vivex Biomedical
11.18.1 Vivex Biomedical Company Detail
11.18.2 Vivex Biomedical Business Overview
11.18.3 Vivex Biomedical Artificial Dermal Matrix Introduction
11.18.4 Vivex Biomedical Revenue in Artificial Dermal Matrix Business (2018-2023)
11.18.5 Vivex Biomedical Recent Development
11.19 Aedicell
11.19.1 Aedicell Company Detail
11.19.2 Aedicell Business Overview
11.19.3 Aedicell Artificial Dermal Matrix Introduction
11.19.4 Aedicell Revenue in Artificial Dermal Matrix Business (2018-2023)
11.19.5 Aedicell Recent Development
11.20 Amniox Medical
11.20.1 Amniox Medical Company Detail
11.20.2 Amniox Medical Business Overview
11.20.3 Amniox Medical Artificial Dermal Matrix Introduction
11.20.4 Amniox Medical Revenue in Artificial Dermal Matrix Business (2018-2023)
11.20.5 Amniox Medical Recent Development
11.21 StimLabs
11.21.1 StimLabs Company Detail
11.21.2 StimLabs Business Overview
11.21.3 StimLabs Artificial Dermal Matrix Introduction
11.21.4 StimLabs Revenue in Artificial Dermal Matrix Business (2018-2023)
11.21.5 StimLabs Recent Development
11.22 Skye Biologics
11.22.1 Skye Biologics Company Detail
11.22.2 Skye Biologics Business Overview
11.22.3 Skye Biologics Artificial Dermal Matrix Introduction
11.22.4 Skye Biologics Revenue in Artificial Dermal Matrix Business (2018-2023)
11.22.5 Skye Biologics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details